Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.

Lachmann, Nico; Brennig, Sebastian; Phaltane, Ruhi; Flasshove, Michael; Dilloo, Dagmar; Moritz, Thomas

Lachmann, Nico; Brennig, Sebastian; Phaltane, Ruhi; Flasshove, Michael; Dilloo, Dagmar; Moritz, Thomas.

Affiliation

Lachmann N; Research Group Reprogramming, REBIRTH Cluster of Excellence, Hannover Medical School, Hannover, Germany.

Neoplasia ; 15(3): 239-48, 2013 Mar.

Article in En | MEDLINE | ID: mdl-23479503

Subject(s)

Cytidine Deaminase/genetics; Gene Transfer Techniques; Leukemia/genetics; Leukemia/therapy; Animals; Antineoplastic Agents/pharmacology; Cytarabine/pharmacology; Drug Resistance, Neoplasm/genetics; Gene Expression; Genetic Therapy/adverse effects; Hematopoietic Stem Cells/metabolism; Humans; Mice; Myelopoiesis/drug effects; Myelopoiesis/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Gene Transfer Techniques / Cytidine Deaminase Limits: Animals / Humans Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google